ArticleMethods in molecular biology (Clifton, N.J.)2025
Detection of De Novo Mutations by Sequencing Reduced Representation Libraries.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
De novo mutations (DNMs) are spontaneous genetic alterations not present in parents but occurring in the germline and transmitted to offspring. These mutations play a vital role in understanding evolutionary processes, genetic diversity, and impacts on species' fitness and survival. The identification of DNMs is especially crucial in the context of environmental stresses, such as those induced by nuclear accidents like Fukushima. This chapter describes recent advances in high-throughput sequencing technologies that have enhanced our capacity to detect DNMs within a single generation. Due to challenges associated with whole-genome resequencing in nonmodel organisms with high genetic and environmental heterogeneity, we proposed the use of genetic marker-based methods like Restriction site-Associated DNA Sequencing (RADSeq). RADSeq simplifies the detection of DNMs by using restriction enzymes to cut DNA at specific sites, producing manageable fragments for sequencing that represent the entire genome. This method allows for the targeted analysis of genetic variations across large populations and is particularly effective in detecting DNMs from wide range of populations, providing insight into damages and adaptations required for different biological conditions.
Indexed as
Identifiers
40418480What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.